The top group of healthcare in the Sultanate of Oman is Taiba healthcare group. Taiba pharmacy group is headed by the Dr. Saif al Hasani who is known as the current CEO of Taiba pharmacy group. He is dedicated to bringing high priced treatments in access of rural families. Now the group has a special focus on the pharmacy products that are directly related to the hospitals (Businesswire.com, 2019). Their offices which deal with the local markets are taibaKSA and taibaME. In the local market, the group also does the marketing and distribution of the niche. The organization has a wide consideration and notable work for marketing and distribution of the pharmacy products of the disease that are quite rare. The mainly targeted field of the group is metabolic disorders and hematology (Businesswire.com, 2019).

           The group Taiba pharma just make a statement in which the official declared that the group is going to launch their own pharmacy project which is named as "Menagene Pharmaceutical Industries” the plan is to manufacture special innovative products. Menagene Pharmaceutical Industries will work as a manufacturing plant to produce medicine and other pharmaceutical products to provide proper treatment and medication to the People of Oman and the Middle East for rare diseases (Businesswire.com, 2019). The project aim is not only limited to the increase of revenue only in fact it is also concerned with the decrease of death and disease rate in Oman and other areas of the Middle East with the best medication. It is highly predicted that the project will flourish in day and night because of its strong and stable international partners. The group deals in and with the retail and can distribute the products of pharmacies. It also does the marketing of such products.  

          The primary markets selected for this purpose are Middle East markets and the markets of North Africa. According to the plan, the plant is to set up in the Muscat, Oman (which is a part of GCC countries). The project will be finished soon and it will begin to work in a few months (Businesswire.com, 2019). The officials hope that the operation will be started soon in 2020. According to the estimates made by the managers, the project may cost more than or less than $50 million dollars. The group of Taiba pharma has the great expectations that the project will change their financial position and will provide strength to their goodwill (Businesswire.com, 2019). 

References of Menagene Pharmaceutical Industries Project of Taiba Group

Businesswire.com. (2019). Taiba pharma group Sets Up New Manufacturing Company “MENAGENE”. Retrieved from www.businesswire.com: https://www.businesswire.com/news/home/20180604005774/en/taiba-pharma-group-Sets-New-Manufacturing-Company

Ducros, M., & Fernet, G. (2010). Project Management Guide. Editions TECHNIP.